NasdaqGS - Delayed Quote USD

Werewolf Therapeutics, Inc. (HOWL)

1.2300
-0.0800
(-6.11%)
At close: June 5 at 4:00:01 PM EDT
1.2700
+0.04
+(3.25%)
Pre-Market: 8:00:01 AM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
1,143
1,885
19,943
16,401
0
Operating Expense
75,566
75,479
60,446
72,457
50,087
Operating Income
-74,423
-73,594
-40,503
-56,056
-50,087
Net Non Operating Interest Income Expense
781
2,017
4,277
1,908
104
Other Income Expense
1,231
1,062
-1,142
338
--
Pretax Income
-72,411
-70,515
-37,368
-53,810
-49,983
Net Income Common Stockholders
-72,411
-70,515
-37,368
-53,810
-201,925
Diluted NI Available to Com Stockholders
-72,411
-70,515
-37,368
-53,810
-201,925
Basic EPS
-1.64
-1.63
-1.05
-1.86
-10.94
Diluted EPS
-1.64
-1.63
-1.05
-1.86
-10.94
Basic Average Shares
44,137.0580
43,332.0880
35,646.5720
28,864
18,455
Diluted Average Shares
44,664.6340
43,859.6640
35,646.5720
28,864
18,455
Total Operating Income as Reported
-74,423
-73,594
-40,503
-56,056
-50,087
Total Expenses
75,566
75,479
60,446
72,457
50,087
Net Income from Continuing & Discontinued Operation
-72,411
-70,515
-37,368
-53,810
-49,983
Normalized Income
-71,858
-69,962
-37,368
-53,810
-49,983
Interest Income
5,697
6,673
7,416
1,908
104
Interest Expense
4,916
4,656
3,139
0
--
Net Interest Income
781
2,017
4,277
1,908
104
EBIT
-67,495
-65,859
-34,229
-53,810
-50,087
EBITDA
-65,719
-64,045
-32,465
-52,706
-49,871
Reconciled Depreciation
1,776
1,814
1,764
1,104
216
Net Income from Continuing Operation Net Minority Interest
-72,411
-70,515
-37,368
-53,810
-49,983
Total Unusual Items Excluding Goodwill
-553
-553
0
--
--
Total Unusual Items
-553
-553
0
--
--
Normalized EBITDA
-65,166
-63,492
-32,465
-52,706
-49,871
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 4/30/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

STRO Sutro Biopharma, Inc.
0.8243
-9.36%
 
BOLD Boundless Bio, Inc.
1.1700
-0.85%
 
XLO Xilio Therapeutics, Inc.
0.6783
+1.86%
 
ELEV Elevation Oncology, Inc.
0.3051
+0.30%
 
ANRO Alto Neuroscience, Inc.
2.3800
-2.86%
 
OLMA Olema Pharmaceuticals, Inc.
4.2100
-0.24%
 
GLUE Monte Rosa Therapeutics, Inc.
4.6200
+0.22%
 
BDTX Black Diamond Therapeutics, Inc.
2.4900
-1.97%
 
STTK Shattuck Labs, Inc.
1.0600
-8.62%
 
IPSC Century Therapeutics, Inc.
0.5630
-0.71%